GlassScriptPhysician profile
Anoop M Shah
NPI 1053671347
$6,263.67
in general payments reported to CMS, 2019-2025
41 companies · $998 in 2025
The $998 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,147 · 2020: $528 · 2021: $582 · 2022: $842 · 2023: $1,017 · 2024: $1,150 · 2025: $998.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,050 · Education: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,049.58 |
| Education | $115.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $565.51 | 2019-2025 | |
| Amgen INC. | $401.44 | 2019-2024 | Repatha |
| Abiomed | $399.37 | 2019-2024 | Impella |
| Astrazeneca Pharmaceuticals LP | $387.04 | 2019-2025 | Wainua, Farxiga |
| Boston Scientific Corporation | $340.48 | 2019-2025 | Watchman Flx |
| Penumbra, INC. | $335.80 | 2019-2025 | Indigo System |
| Abbott Laboratories | $314.35 | 2020-2025 | Diamondback Coronary, Thoratec Heartmate 3 Lvas Implant Kit |
| Cardiovascular Systems INC. | $314.27 | 2019-2022 | |
| Shockwave Medical, INC | $272.86 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $272.09 | 2019-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $271.98 | 2019-2024 | Xarelto |
| Pfizer INC. | $271.17 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $238.03 | 2019-2025 | Lifevest |
| Actelion Pharmaceuticals US, INC. | $215.68 | 2019-2024 | Opsumit, Uptravi |
| E.R. Squibb & Sons, L.L.C. | $209.74 | 2022-2025 | Camzyos, Eliquis |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $200.53 | 2023-2025 | |
| Impulse Dynamics (USA) INC. | $142.64 | 2022-2024 | Optimizer, Optimizer |
| Medtronic, INC. | $133.76 | 2023 | Onyx Frontier, Corevalve Evolut R |
| Novo Nordisk INC | $109.38 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Astellas Pharma US INC | $90.32 | 2019 | |
| Merck Sharp & Dohme LLC | $87.63 | 2021-2025 | Verquvo |
| Chiesi USA, INC. | $71.58 | 2019-2020 | |
| Kestra Medical Technology Services, INC. | $62.48 | 2025 | Assure Wcd |
| Esperion Therapeutics, INC. | $59.87 | 2022-2024 | Nexletol |
| Kiniksa Pharmaceuticals, LTD. | $55.01 | 2022-2023 | Arcalyst |
| Alnylam Pharmaceuticals INC. | $51.67 | 2025 | Onpattro |
| Atricure, INC. | $46.50 | 2024 | |
| Cardiva Medical, INC. | $42.90 | 2019-2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Heartflow, INC. | $40.64 | 2025 | |
| Portola Pharmaceuticals, LLC | $36.14 | 2019 | |
| Scpharmaceuticals INC. | $31.30 | 2025 | |
| Zoll Circulation INC | $26.45 | 2025 | Downstream Cartridge, Catheter, Therox Ds2 Console |
| Regeneron Healthcare Solutions, INC. | $25.68 | 2024 | Evkeeza |
| Asahi Intecc USA, INC. | $22.24 | 2025 | Asahi Peripheral Vascular Wires |
| Philips North America LLC | $21.28 | 2019 | |
| Glaxosmithkline, LLC. | $19.70 | 2025 | Shingrix, Arexvy |
| Sanofi-Aventis U.S. LLC | $17.40 | 2021 | |
| Medicomp INC | $17.08 | 2022 | |
| Terumo Medical Corporation | $16.62 | 2024 | R2p Misago, Navicross, Metacross Otw |
| Amarin Pharma, INC. | $13.08 | 2021 | |
| Itamar Medical INC | $11.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anoop Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.